Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q2- Text added to 2012 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
AKT, alpha, Amgen, area, Asia, backup, beta, bioavailability, body, cellular, delta, dexamethasone, differentiated, differentiation, Diffuse, Echelard, exhibited, family, fold, Follicular, gamma, gene, Gilead, hematopoietic, Ildong, immunity, implicated, India, Infinity, inhibition, inhibitor, intracellular, isoform, Korea, leukemic, lipopolysaccharide, LPS, Marginal, Myeloma, nanomolar, noncontrolling, phosphorylation, Potent, proliferation, reelection, regimen, resistant, Rhizen, signaling, South, Southeast, stand, steroid, stratified, strongly, subtype, territory, trafficking, tumor, unexpected, unfamiliar, upfront, world, Yann, Zone
Removed:
average, exploring, noncurrent, reserved, weighted
Valuein 2012 Q2 filing- Value in 2012 Q3 filing
Original filings
Filing view